Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: A potential strategy to prevent the development of cardiac hypertrophy

Canadian Journal of Physiology and Pharmacology

Volumn 83, Issue 1, 2005, Pages 24-28

  Chan, Anita Y M ^a   Dyck, Jason R B ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

AMPK; Cardiac hypertrophy; Cardiac myocyte; Energy metabolism; Protein synthesis

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANIMAL CELL; CONFERENCE PAPER; ENERGY BALANCE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RNA TRANSLATION;

ANIMALS; CARDIOMEGALY; ENERGY METABOLISM; ENZYME ACTIVATION; HUMANS; MULTIENZYME COMPLEXES; PEPTIDE ELONGATION FACTOR 2; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 19944408988     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y04-107     Document Type: Conference Paper

References (48)

1. Blair, E., Redwood, C., Ashrafian, H., Oliveira, M., Broxholme, J., Kerr, B. et al. 2001. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet. 10: 1215-1220.
2. Bolster, D.R., Crozier, S.J., Kimball, S.R., and Jefferson, L.S. 2002. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem. 277: 23977-23980.
3. Browne, G.J., and Proud, C.G. 2002. Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269: 5360-5368.
4. Browne, G.J., and Proud, C.G. 2004. A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin. Mol. Cell. Biol. 24: 2986-2997.
5. Browne, G.J., Finn, S.G., and Proud, C.G. 2004. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J. Biol. Chem. 279: 12220-12231.
6. Chan, A.Y., Soltys, C.L., Young, M.E., Proud, C.G., and Dyck, J.R. 2004. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J. Biol. Chem. 279: 32771-32779.
7. Cheng, S.W., Fryer, L.G., Carling, D., and Shepherd, P.R. 2004. Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J. Biol. Chem. 279: 15719-15722.
8. Cheung, P.C., Salt, I.P., Davies, S.P., Hardie, D.G., and Carling, D. 2000. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 346(3): 659-669.
9. Daniel, T., and Carling, D. 2002. Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J. Biol. Chem. 277: 51017-51024.
10. Diggle, T.A., Subkhankulova, T., Lilley, K.S., Shikotra, N., Willis, A.E., and Redpath, N.T. 2001. Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+/calmodulin-independent activity. Biochem. J. 353: 621-626.
11. Dubbelhuis, P.F., and Meijer, A.J. 2002. Hepatic amino acid-dependent signaling is under the control of AMP-dependent protein kinase. FEBS Lett. 521: 39-42.
12. Dyck, J.R.B., Gao, G., Widmer, J., Stapleton, D., Fernandez, C.S., Kemp, B.E., and Witters, L.A. 1996. Regulation of 5′-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. J. Biol. Chem. 271: 17798-17803.
13. Fingar, D.C., Salama, S., Tsou, C., Harlow, E., and Blenis, J. 2002. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16: 1472-1487.
14. Frey, N., and Olson, E.N. 2003. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65: 45-79.
15. Gao, G., Fernandez, C.S., Stapleton, D., Auster, A.S., Widmer, J., Dyck, J.R. et al. 1996. Non-catalytic beta- and gamma-subunit isoforms of the 5′-AMP-activated protein kinase. J. Biol. Chem. 271: 8675-8681.
16. Gollob, M.H., Green, M.S., Tang, A.S., Gollob, T., Karibe, A., Ali Hassan, A.S. et al. 2001. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N. Engl. J. Med. 344: 1823-1831.
17. Hardie, D.G., and Carling, D. 1997. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem. 246: 259-273.
18. Hawley, S.A., Davison, M., Woods, A., Davies, S.P., Beri, R.K., Carling, D., and Hardie, D.G. 1996. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271: 27879-27887.
19. Horman, S., Browne, G., Krause, U., Patel, J., Vertommen, D., Bertrand, L. et al. 2002. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr. Biol. 12: 1419-1423.
20. Horman, S., Beauloye, C., Vertommen, D., Vanoverschelde, J.L., Hue, L., and Rider, M.H. 2003. Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2. J. Biol. Chem. 278: 41970-41976.
21. Inoki, K., Zhu, T., and Guan, K.L. 2003. TSC2 mediates cellular energy response to control cell growth and survival. Cell, 115: 577-590.
22. Isotani, S., Hara, K., Tokunaga, C., Inoue, H., Avruch, J., and Yonezawa, K. 1999. Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro. J. Biol. Chem. 274: 34493-34498.
23. Kimura, N., Tokunaga, C., Dalal, S., Richardson, C., Yoshino, K., Hara, K. et al. 2003. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells, 8: 65-79.
24. Knebel, A., Morrice, N., and Cohen, P. 2001. A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta. EMBO J. 20: 4360-4369.
25. Knebel, A., Haydon, C.E., Morrice, N., and Cohen, P. 2002. Stress-induced regulation of eukaryotic elongation factor 2 kinase by SB 203580-sensitive and -insensitive pathways. Biochem. J. 367: 525-532.
26. Kobayashi, T., Minowa, O., Kuno, J., Mitani, H., Hino, O., and Noda, T. 1999. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res. 59: 1206-1211.
27. Krause, U., Bertrand, L., and Hue, L. 2002. Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. Eur. J. Biochem. 269: 3751-3759.
28. Krymskaya, V.P. 2003. Tumour suppressors hamartin and tuberin: intracellular signalling. Cell Signal. 15: 729-739.
29. Kwiatkowski, D.J. 2003. Tuberous sclerosis: from tubers to mTOR. Ann. Hum. Genet. 67: 87-96.
30. Lorell, B.H., and Carabello, B.A. 2000. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation, 102: 470-479.
31. McLeod, L.E., and Proud, C.G. 2002. ATP depletion increases phosphorylation of elongation factor eEF2 in adult cardiomyocytes independently of inhibition of mTOR signalling. FEBS Lett. 531: 448-452.
32. Ponticos, M., Lu, Q.L., Morgan, J.E., Hardie, D.G., Partridge, T.A., and Carling, D. 1998. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J. 17: 1688-1699.
33. Proud, C.G. 1996. p70 S6 kinase: an enigma with variations. Trends Biochem. Sci. 21: 181-185.
34. Proud, C.G. 2002. Regulation of mammalian translation factors by nutrients. Eur. J. Biochem. 269: 5338-5349.
35. Proud, C.G. 2004. mTOR-mediated regulation of translation factors by amino acids. Biochem. Biophys. Res. Commun. 313: 429-436.
36. Redpath, N.T., and Proud, C.G. 1993. Purification and phosphorylation of elongation factor-2 kinase from rabbit reticulocytes. Eur. J. Biochem. 212: 511-520.
37. Redpath, N.T., Price, N.T., Severinov, K.V., and Proud, C.G. 1993. Regulation of elongation factor-2 by multisite phosphorylation. Eur. J. Biochem. 213: 689-699.
38. Redpath, N.T., Foulstone, E.J., and Proud, C.G. 1996. Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J. 15: 2291-2297.
39. Richey, P.A., and Brown, S.P. 1998. Pathological versus physiological left ventricular hypertrophy: a review. J. Sports Sci. 16: 129-141.
40. Stapleton, D., Gao, G., Michell, B.J., Widmer, J., Mitchelhill, K., Teh, T. et al. 1994. Mammalian 5′-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. J. Biol. Chem. 269: 29343-29346.
41. Stein, S.C., Woods, A., Jones, N.A., Davison, M.D., and Carling, D. 2000. The regulation of AMP-activated protein kinase by phosphorylation. Biochem. J. 345(3): 437-443.
42. Sugden, P.H., and Clerk, A. 1998. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76: 725-746.
43. Terada, N., Patel, H.R., Takase, K., Kohno, K., Nairn, A.C., and Gelfand, E.W. 1994. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc. Natl. Acad. Sci. USA, 91: 11477-11481.
44. Tian, R., Musi, N., D'Agostino, J., Hirshman, M.F., and Goodyear, L.J. 2001. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation, 104: 1664-1669.
45. van Slegtenhorst, M., Nellist, M., Nagelkerken, B., Cheadle, J., Snell, R., van den Ouweland, A. et al. 1998. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum. Mol. Genet. 7: 1053-1057.
46. Wang, L., Wang, X., and Proud, C.G. 2000. Activation of mRNA translation in rat cardiac myocytes by insulin involves multiple rapamycin-sensitive steps. Am. J. Physiol. Heart Circ. Physiol. 278: H1056-H1068.
47. Wang, X., Li, W., Williams, M., Terada, N., Alessi, D.R., and Proud, C.G. 2001. Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J. 20: 4370-4379.
48. Woods, A., Cheung, P.C., Smith, F.C., Davison, M.D., Scott, J., Beri, R.K., and Carling, D. 1996. Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. J. Biol. Chem. 271: 10282-10290.